Inspirali consolidates Ânima’s portfolio of medical schools and positions itself as a platform for medical education and lifelong learning in Brazil. The unit reached nearly 10,000 undergraduate students in 2021, a >300% increase year-on-year, and already accounts for 25% of Ânima’s net revenue. Recent moves include the November acquisition of 51% of IBCMED (postgraduate health courses) and launch of an Inspirali-integrated curriculum across former Laureate schools for the 2022 academic year. The group also secured MEC authorization for a Medicine course in Brumado (BA) in December 2021. Planned initiatives emphasize strengthening ties between academia and healthcare, scaling a lifelong-learning platform, driving educational-innovation networks, and improving student experience and employability. Leadership reports recent operational reinforcement, strategic expansion, academic integration and technology investment to prepare Inspirali for accelerated growth.

Total raised

$211M

Funding rounds

1

Latest round

Equity

Latest activity

Apr 2022